Ankur Dhingra, Chief Financial Officer at Summit Therapeutics Inc. (SMMT), bought 13,027 shares at $0.97 ($13K) on 2022-08-16, disclosed to the SEC on 2023-03-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SMMT | BUY | 2023-12-13 | $44K | — | Filing → |
| SMMT | BUY | 2023-03-08 | $412K | — | Filing → |
| SMMT | BUY | 2022-08-17 | $35K | — | Filing → |